Tag:

Velothrax

Latest Headlines

Latest Headlines

Soligenix, Infectious Disease Research Institute partner to combat anthrax

July 2, 2012 | By
Soligenix, a Princeton, NJ-based biopharmaceutical company, will partner with the Infectious Disease Research Institute of Seattle, to develop biodefense vaccines.
Related Tags
Press Releases
  • AMRI to Acquire Aptuit Drug Product Development and Aseptic Clinical Manufacturing Businesses
  • Exosome Diagnostics and the Addario Lung Cancer Medical Institute (ALCMI) Announce Collaboration to Accelerate Development of Plasma-Based Lung Cancer Diagnostics
  • Record number of medicines for rare diseases recommended for approval in 2014
  • DiaCarta raises $8 million in Series A financing from BVCF
  • FDA approves anti-clotting drug Savaysa
  • More Press Releases
Sponsored Links